| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.38B | 14.18B | 14.49B | 20.03B | 15.84B | 10.04B |
| Gross Profit | 3.89B | 3.07B | 2.44B | 6.51B | 5.22B | 2.24B |
| EBITDA | 3.18B | 2.37B | 1.87B | 4.62B | 3.81B | 1.58B |
| Net Income | 1.28B | 810.80M | 707.79M | 3.86B | 2.07B | 772.17M |
Balance Sheet | ||||||
| Total Assets | 22.13B | 20.94B | 21.95B | 24.64B | 21.60B | 17.12B |
| Cash, Cash Equivalents and Short-Term Investments | 3.77B | 2.75B | 3.13B | 5.45B | 5.25B | 4.43B |
| Total Debt | 70.56M | 26.44M | 32.05M | 43.63M | 664.26M | 1.95B |
| Total Liabilities | 3.51B | 3.47B | 5.01B | 6.15B | 5.96B | 6.59B |
| Stockholders Equity | 12.98B | 12.11B | 14.79B | 16.08B | 13.12B | 8.54B |
Cash Flow | ||||||
| Free Cash Flow | 309.32M | 278.14M | -536.56M | 1.24B | -43.38M | 525.19M |
| Operating Cash Flow | 1.66B | 2.07B | 1.38B | 5.08B | 3.91B | 2.26B |
| Investing Cash Flow | -1.32B | -1.50B | -2.63B | -2.91B | -4.09B | -1.96B |
| Financing Cash Flow | -192.98M | -648.37M | -1.51B | -1.96B | 999.52M | 1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$9.36B | -30.98 | -11.33% | ― | 29.64% | -3.91% | |
69 Neutral | HK$4.08B | 7.74 | 6.29% | 6.70% | -3.73% | 6.09% | |
62 Neutral | HK$18.88B | 10.18 | 10.22% | 0.98% | -1.43% | 113.67% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | HK$1.24B | 7.69 | 3.65% | 2.20% | -8.51% | -68.34% | |
54 Neutral | HK$13.54B | 87.42 | -0.50% | 1.16% | -15.17% | -125.24% | |
52 Neutral | HK$5.97B | 8.07 | 13.43% | ― | 9.20% | 213.87% |